AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

The U.S. Food and Drug Administration approved the Keytruda combination in malignant pleural mesothelioma in September. Keytruda, a cancer drug that harnesses a patient's immune system to fight tumors ...

Fintel reports that on November 15, 2024, Wolfe Research initiated coverage of Merck (NYSE:MRK) with a Peer Perform ...

Dr. Vink brings over 35 years of industry experience and currently serves as Chairman and Board member of several public and ...

Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks ’World Diabetes Day 2024’ together with Africa’s First Ladies, Ministries of Health, Medical Societies and Academia, through their ...

ShareIn commemoration of the 2024 World Diabetes Day, Merck Foundation, the philanthropic arm of Merck KGaA Germany, has ...

Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.

South-East Asia will now have its first dedicated Process Technology show with the launch of Process Innovation Asia Pacific ...

Vietnam Expands for 2025 with Addition of New Hall - The largest edition yet, nearly double the size of the 2023 edition. - ...

Attend Pittcon 2025 in Boston to connect with global leaders in laboratory science and explore cutting-edge advancements in ...

People visit the China Pavilion during the 7th China International Import Expo (CIIE) in Shanghai, November 5, 2024. The ...

ShareHealth, they say is wealth. Sadly, many persons are finding it difficult to access quality health services for various ...